Repositorio Dspace

Listar por autor "Cabanas-Perianes, Valentín"

Listar por autor "Cabanas-Perianes, Valentín"

Ordenar por:Orden:Resultados:

  • A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometry 
    Puig, Noemi; Agullo, Cristina; Paiva, Bruno; Cedeña, María-Teresa; Rosinol, Laura; Contreras, Teresa; Martínez-lopez, Joaquín; Oriol, Albert; Blanchard, María-Jesús; Ríos-tamayo, Rafael; Sureda, Anna; Lakhwani, Sunil; de-La-Rubia, Javier; Cabanas-Perianes, Valentín; de-Arriba-de-la-Fuente, Felipe; Paricio, Miguel; Inigo, María-Belén; González-calle, Verónica; Ocio, Enrique-M; Castro, Sergio; Bargay, Joan; Blade, Joan; San-Miguel, Jesus-F; Lahuerta, Juan-José; Mateos, María-Victoria (WILEY, 2026-02)
  • Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma 
    Zugas, Inés; Tormo-Ratera, Marta; Oliver-Caldes, Aina; Soler-Perromat, Juan-Carlos; González-Calle, Veronica; Moreno, David-F; Cabanas-Perianes, Valentín; López-Muñoz, Nieves; Bartolome-Solanas, Álvaro; Español-Rego, Marta; Reguera-Ortega, Juan-Luis; Rosinol, Laura; López-Corral, Lucía; Tovar, Natalia; Rodríguez-Lobato, Luis-Gerardo; Álvarez-Pérez, Rosa-María; Varea, Sara; Olesti, Eulalia; Gómez-Grande, Adolfo; Frutos-Esteban, Laura; Tamayo, Pilar; Juan, Manel; Moraleda-Jiménez, José-María; Urbano-Ispizua, Álvaro; González-Navarro, Europa-Azucena; Martínez-López, Joaquín; Mateos, María-Victoria; Tomas, Xavier; Setoain, Xavier; Fernández-de-Larrea, Carlos (ELSEVIER, 2025-02-11)
    Multiple myeloma (MM) remains incurable, with poor outcomes in heavily pretreated patients. Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising treatment; however, outcomes after such therapy in ...
  • High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy 
    Manubens, Andrea; Paiva, Bruno; Gutiérrez, Norma-C; Fernández, Manuela; Calasanz, María-José; Rosinol, Laura; Oriol, Albert; Blanchard, Ma-Jesús; Carrillo, Estrella; Benavente, Celina; Martínez-López, Joaquín; Bargay, Joan; Hernández, Miguel-Teodoro; de-la-Rubia, Javier; González, Yolanda; Paricio, Miguel; de-Arriba-de-la-Fuente, Felipe; Ocio, Enrique-M; Teruel, Ana-Isabel; López-de-la-Guía, Ana; Sirvent, Maialen; Gironella, Mercedes; Sampol, Antonia; Arguiñano, José-María; Cabrera, Carmen; Alegre, Adrián; Granell, Miquel; Cabanas-Perianes, Valentín; Núñez-Córdoba, Jorge-M; Mateos, María-Victoria; Lahuerta, Juan-José; San-Miguel, Jesús-F; Blade, Joan; Rodríguez-Otero, Paula (WILEY, 2025-04)
    Patients with newly-diagnosed multiple myeloma (MM) who experience early relapse (ER) have dismal overall survival (OS). Their prospective identification, either before or soon after treatment initiation, is paramount to ...
  • Intestinal Perforation Secondary to Bortezomib-Induced Autonomic Neuropathy 
    Sánchez-Salas, José-Antonio; Moreno-Belmonte, María-José; Poveda-García, Andrea; Ruiz-Ruiz, Estela; Soler-Espejo, Eva; Cabanas-Perianes, Valentín; García-Hernández, Ana-María (WILEY, 2025-04)
    It is essential to evaluate both the patient's prior conditions and the severity of the current clinical presentation when deciding on BTZ toxicity management. It seems prudent to consider the permanent discontinuation of ...
  • Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h 
    Munarriz, Daniel; Rodríguez-Lobato, Luis-Gerardo; López-Corral, Lucía; Arnaldos-Pérez, Cristina; Cabanas-Perianes, Valentín; López-Muñoz, Nieves; Oliver-Caldes, Aina; Ponce, Juan-Carlos; Reguera, Juan-Luis; Martin, Ana-Africa; Martínez-Cibrian, Nuria; Tovar, Natalia; Delgado, Julio; Guillen, Elena; Varea, Sara; Rodríguez-Otero, Paula; Urbano-Ispizua, Álvaro; Moraleda-Jiménez, José-María; Martínez-López, Joaquín; Mateos, María-Victoria; González-de-la-Calle, Veronica; González-Navarro, Europa-Azucena; Fernández-de-Larrea, Carlos (FRONTIERS MEDIA SA, 2025-10-16)
    BACKGROUND: Chimeric antigen receptor T-cell (CAR-T) therapy targeting B-cell maturation antigen (BCMA) has revolutionized multiple myeloma treatment (MM). However, managing its immune-mediated adverse events, particularly ...
  • Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma 
    Puig, Noemi; Contreras, María-Teresa; Agulló, Cristina; Martínez-López, Joaquín; Oriol, Albert; Blanchard, María-Jesús; Ríos, Rafael; Martín, Jesús; Iñigo, María-Belén; Sureda, Anna; Hernández-García, Miguel-Teodoro; de-la-Rubia, Javier; González-Calle, Verónica; Krsnik, Isabel; Cabanas-Perianes, Valentín; Palomera, Luis; Moraleda-Jiménez, José-María; Bargay, Joan; Cedena, María-Teresa; Paiva, Bruno; Rosiñol, Laura; Blade, Joan; San-Miguel, Jesús-F; Lahuerta, Juan-José; Mateos, María-Victoria (ELSEVIER, 2022-06)
    Monitoring of the monoclonal protein (M-protein) by electrophoresis and/or immunofixation (IFE) has long been used to assess treatment response in multiple myeloma (MM). However, with the use of highly effective therapies, ...
  • Observational retrospective study of the treatment of Waldenström's macroglobulinemia with ibrutinib in routine clinical practice in Spain 
    Fernández-de-Larrea, Carlos; Loscertales, Javier; Cabanas-Perianes, Valentín; Freiria, Carmen; Blanchard, María-Jesús; Askari, Elham; Lorenzo-Pérez, Marcos; Abril-Parreño, Laura; López-Pardo, Jordi; Pinzón, Sergio; Díaz-Galvez, Javier; Amer, Neus; Ramírez-Payer, Ángel; García-Sánchez, Ricarda; Alcalá, María-Magdalena; Capote, Francisco-Javier; Moreno, David; Bolumburu, Celia; Rubio-Azpeitia, Eva; García-Sanz, Ramón (SAGE PUBLICATIONS LTD, 2025-07)
  • Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma 
    Tamariz-Amador, Luis-Esteban; Rodríguez-Otero, Paula; Jiménez-Ubieto, Ana; Rosiñol, Laura; Oriol, Albert; Ríos, Rafael; Sureda, Anna; Blanchard, María-Jesús; Teodoro-Hernández, Miguel; Cabanas-Perianes, Valentín; Jarque, Isidro; Bargay, Juan; Gironella, Mercedes; de-Arriba-de-la-Fuente, Felipe; Palomera, Luis; González-Montes, Yolanda; Marti, Josep-M; Krsnik, Isabel; Arguiñano, JM; Esther-González, María; Felipe-Casado, Luis; González-Rodríguez, Ana-Pilar; López-Anglada, Lucía; Puig, Noemi; Cedena, María-Teresa; Paiva, Bruno; Mateos, María-Victoria; San-Miguel, Jesús-F; Lahuerta, Juan-José; Blade, Joan; Troconiz, Inaki-F (CIG MEDIA GROUP, LP, 2022-09)
    INTRODUCTION: Response kinetics is a well-established prognostic marker in acute lymphoblastic leukemia. The situation is not clear in multiple myeloma (MM) despite having a biomarker for response monitoring (monoclonal ...
  • Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms 
    Vasco-Mogorron, María-A; Campillo, José-Antonio; Periago, Adela; Cabanas-Perianes, Valentín; Berenguer, Mercedes; García-Garay, María-Carmen; Gimeno, Lourdes; Soto-Ramírez, María-F; Martínez-Hernández, María-Dolores; Muro-Pérez, Manuel; Minguela-Puras, Alfredo (MDPI, 2021-04)
    Proliferation and apoptosis of neoplastic cells are prognostic biomarkers in plasma cell neoplasms (PCNs). The prognostic capacity of proliferation to apoptosis ratio (Ratio-PA) in the era of immunomodulatory treatments ...
  • Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cells 
    Ortiz-de-Landazuri, Iñaki; Oliver-Caldes, Aina; Espanol-Rego, Marta; Agulló, Cristina; Contreras, María-Teresa; Zabaleta, Aintzane; Puig, Noemi; Cabanas-Perianes, Valentín; González-Calle, Verónica; Zugasti, Inés; Inoges, Susana; Rodríguez-Otero, Paula; Martín-Antonio, Beatriz; Reguera, Juan-Luis; López-Díaz-de-Cerio, Ascensión; Aróstegui, Juan-I; Uribe-Herranz, Mireia; Benítez-Ribas, Daniel; Rodríguez-Lobato, Luis-Gerardo; González, Europa-Azucena; Tovar, Natalia; Charry, Paola; Navarro, Sergio; Rosiñol, Laura; Treboles, Karen; Mora, Genesis; Yagüe, Jordi; Moraleda-Jiménez, José-María; Urbano-Ispizua, Álvaro; Mateos, María-Victoria; Pascal, Mariona; Paiva, Bruno; Juan, Manel; Fernández-de-Larrea, Carlos (WILEY, 2024-10)
    Chimeric antigen receptor (CAR) T-cell therapies have increased the patients with relapsed/refractory multiple myeloma (RRMM) in whom standard electrophoretic techniques fail to detect the M-protein. Quantitative ...
  • Shared Decision-Making in Treatment Selection in Multiple Myeloma in Spain: The PRISMMA Study 
    Cabanas-Perianes, Valentín; Casanova, María; Barragán, Begoña; López, Isabel; Raya, Anna; Santiago-Josefat, Belén (WILEY, 2026-02)
    INTRODUCTION: Perceptions and experiences of shared decision-making between patients and physicians in multiple myeloma (MM) care are not fully understood. A survey study was conducted to explore these perspectives in ...